期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 140, 期 2, 页码 171-177出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1016/j.jphs.2019.06.005
关键词
mu-opioid receptor; Hydromorphone; Biased agonist; beta-arrestin; G protein
资金
- JSPS KAKENHI [JP15K08686, JP15K10522, JP15K08215, JP16K08568, JP18K07404, JP18K08858]
- National Cancer Center Research and Development Fund [29-seeds-5]
- Nakatomi Foundation
- Daiichi Sankyo Co., Ltd.
Morphine, fentanyl, and oxycodone are widely used as analgesics, and recently hydromorphone has been approved in Japan. Although all of these are selective for mu-opioid receptors (MORs) and have similar structures, their analgesic potencies and adverse effects (AEs) are diverse. Recent molecular analyses of MOR signaling revealed that the G protein-mediated signaling pathway causes analgesic effects and the beta-arrestin-mediated signaling pathway is responsible for AEs. We used several cell-based analyses that selectively measure cellular responses activated by either G protein-or beta-arrestin-mediated pathways. GloSensor (TM) cAMP, CellKey (TM), and receptor internalization assays were performed with four different types of cells stably expressing differentially labelled MOR. EC50 values measured by cAMP and CellKey T assays had potencies in the order fentanyl <= hydromorphone < morphine <= oxycodone, all also exhibiting full agonist responses. However, in the internalization assay, only fentanyl elicited a full agonist response. Hydromorphone had the strongest potency next to fentanyl; however, contribution of the beta-arrestin-mediated pathway was small, suggesting that its effect could be biased toward the G protein-mediated pathway. Based on these properties, hydromorphone could be chosen as an effective analgesic. (C) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据